Appropriate use of immune checkpoint inhibitors and immunotherapy differs in adults with unresectable, metastatic cutaneous ...
Clinical utility may be greatest with careful patient selection, given frailty-associated toxicity and potential endpoint inflation in indolent tumors, warranting larger validation cohorts and ...
OU Health Stephenson Cancer Center told News 9 on Sunday that it is the only site in Oklahoma that offers a new cell therapy to treat advanced melanoma. OU Health Stephenson Cancer Center told News 9 ...
After surgery to decrease the odds of the cancer returning If a person is unable to undergo surgery, for example if their health does not allow it or if the melanoma is in a hard-to-reach place To ...
Surgery is usually the main treatment for most types and stages of melanoma. If your tumor is in an early stage and removed using a melanoma surgical treatment, you may not need any other treatment.
Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAFV600E Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H Homologous recombination deficiency ...
Using less ipilimumab appears to make melanoma immunotherapy both safer and more effective, with dramatically better response and survival outcomes. The findings suggest that reducing side effects may ...
The 2-year overall survival rate was 34.3% for Hispanic patients compared to 42.0% for non-Hispanic patients. Hispanic patients with metastatic cutaneous melanoma have worse survival outcomes than non ...
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results